Estrogen pills are convenient for hormone therapy but there are serious risks you need to discuss with your doctor
*IV Ketamine, NR, and NAD+ have been used clinically off-label for decades. They are not FDA approved for the treatment of any psychiatric or pain condition. All medical treatments carry risks and benefits that you must discuss with a doctor at Clarus Health to learn if these therapies are right for you.

Estrogen pills are a common form of hormone replacement therapy - but oral estrogen pills carry unique risks that patches and creams don't. Here's what every woman should understand before starting them.
Estrogen pills are widely prescribed for menopause and hormone replacement, and for many women, they work well. They're convenient, well-studied, and can meaningfully improve quality of life. But here's the problem: the way a pill is absorbed changes how it behaves in your body - and that difference has real consequences.
Estrogen pills are oral tablets - most commonly estradiol (identical to what your body makes) or conjugated equine estrogens (CEE, sold as Premarin).
When you take estrogen pills orally, they pass through your gut and get metabolized by your liver before entering your bloodstream - a process called first-pass hepatic metabolism. This is crucial because the liver in turn increases increasing production of certain proteins, including clotting factors. This causes the main risk between estrogen pills and other forms of estrogen.

When used in the right patient at the right dose, oral estrogen can be genuinely life-changing. Well-documented benefits include:
The liver causes the main difference between estrogen pills, patches, and creams. Because pills are processed by the liver, the liver ramps up production of clotting factors. This mirrors what happens during pregnancy, when rising estrogen levels help prepare the body for the blood loss of childbirth. In that context it's protective. When this happens in non-pregnant woman though, it can be disastrous if it leads to a blood clot or strake.
Transdermal estrogen — patches, gels, and creams — bypasses the liver entirely, which is why multiple large studies show substantially lower blood clot risk with transdermal forms compared to oral.
Oral estrogen increases the risk of venous thromboembolism (VTE) — clots in the deep veins or lungs — and modestly raises stroke risk in certain populations. This risk varies by dose, formulation, age, and individual clotting history, but it is consistently higher with oral forms than with transdermal alternatives.
Surgery already elevates clotting risk. Orthopedic procedures like hip and knee replacements add immobilization on top of that. For women on oral estrogen, these two risk factors compound each other. Most guidelines recommend discussing whether to pause or switch oral estrogen before major surgery — but that conversation can only happen if your surgical team knows you're on it.
I want to be direct about something: women are more likely to have hormone-related questions dismissed in clinical settings. It's a real problem my patients face, and it's why some women end up managing HRT on their own — online, or through compounding pharmacies, without telling their other doctors. I understand why that happens. But the cost of that silence can be serious, and your surgeon and anesthesiologist need to know everything going into your body before you go under.
The relationship between estrogen and breast cancer is highly context-dependent. Estrogen-alone therapy carries a different risk profile than estrogen plus a synthetic progestogen. The type of progestogen also matters — synthetic progestins carry more risk than bioidentical progesterone. Dose, duration, and timing since menopause all factor in. The Women's Health Initiative data is frequently misapplied to all HRT when it applies only to specific types of hormones - this is an area where individualized clinical assessment is not optional.
The hormone matters, but so does how it gets into your body. Here's a comparison:
For many women, oral estrogen is entirely appropriate. For women with any cardiovascular risk factors, a history of clots, or an upcoming surgery, transdermal is generally the safer starting point.
Hormone replacement isn't a one-size prescription. The form of delivery, the type of estrogen and progestogen, the dose, and how it interacts with your other hormones all matter clinically. This is one of the most nuanced areas in medicine, and it's why I don't approach BHRT with a generic protocol.
At Clarus Health, we test over 150 biomarkers and build a hormone protocol around your actual biology, not population averages. If you've had hormone questions brushed off before, or if you're managing this on your own and want to do it safely, I'd encourage you to schedule a free consultation — we can talk through what makes sense for you specifically.